CAS: 1424357-72-1

VS1 is a novel synthetic peptide, which is engineered to function as an antimicrobial agent. This peptide originates from recombinant DNA technology, providing a customizable approach to target specific microbial strains. Its mode of action involves the selective disruption of microbial cell membranes, leading to the lysis and consequent death of the target cell. The specificity of VS1 for microbial cells over mammalian cells minimizes off-target effects, making it a highly effective agent for infection control. The applications of VS1 are diverse within the scientific and medical communities. It is particularly useful in the study of microbial resistance, offering insights into the development of new antimicrobial therapies. VS1 has potential applications in clinical settings for treating infections resistant to traditional antibiotics. Researchers harness VS1 in laboratory experiments aimed at understanding microbial physiology and in developing new methods for microbial detection. Overall, VS1 serves as an invaluable tool for advancing the field of microbiology and infectious disease research, providing novel solutions to combat persistent and resistant microbial infections.